This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Bioagency Ag. Active years: 2008-2011.
Company Filing History:
Years Active: 2008-2011
Title: Armin Reichenberg: Innovator in Organophosphorous Compounds
Introduction
Armin Reichenberg is a notable inventor based in Butzbach, Germany. He has made significant contributions to the field of organophosphorous compounds, particularly in their application for activating gamma/delta T cells. With a total of 2 patents to his name, Reichenberg's work is paving the way for advancements in medical treatments.
Latest Patents
Reichenberg's latest patents include innovative organophosphorous compounds designed for the activation of gamma/delta T cells. The first patent describes these compounds of general formula (I), detailing their preparation and uses in the activation of gamma/delta T-cells. This invention also highlights their potential in screening GcpE and LytB enzyme inhibitors, as well as their application in the prophylaxis and treatment of diseases in both humans and animals. The second patent mirrors the first, emphasizing the same compounds and their multifaceted uses in medical science.
Career Highlights
Armin Reichenberg is currently associated with Bioagency AG, where he continues to explore the potential of organophosphorous compounds. His work is characterized by a commitment to innovation and a focus on improving health outcomes through scientific research.
Collaborations
Reichenberg collaborates with talented individuals such as Hassan Jomaa and Oliver Wolf. Their combined expertise contributes to the advancement of research in their field.
Conclusion
Armin Reichenberg's contributions to the field of organophosphorous compounds are significant and impactful. His innovative patents and collaborations reflect a dedication to advancing medical science and improving health treatments.